You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Litigation Details for Genentech, Inc. v. Celltrion, Inc. (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Biologic Drugs cited in Genentech, Inc. v. Celltrion, Inc.

Details for Genentech, Inc. v. Celltrion, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-04-23 19 U.S. Patent No. 7,390,660 (“the ’660 patent”); 5 (xiii) U.S. Patent No. 7,449,184 (“the … 18 enforce the ’660 patent. 19 63. U.S. Patent No. 7,449,184 (Exhibit 13), titled “…Declaratory Judgment of Non-Infringement of U.S. Patent No. 7,449,184 10 233. Plaintiffs restate…Declaratory Judgment of Invalidity of U.S. Patent No. 7,449,184 7 239. Plaintiffs restate…; 6,627,196; 6,716,602; 7,371,379; 7,390,660; 7,449,184; 16 7,485,704; 7,501,122; 7,807,799; 7,846,441 External link to document
2018-05-21 26 Redacted Document ) 6,121,428 7,449,184 8,574,869 6,242,177…design patents and other types of patents, by imposing apportionment concept to design patent damages… for other patents). Similarly, issuances of design patents outpaced other patents (4.8% for … 16 identifying which patents will be the subject of “immediate” patent infringement litigation. … bring patent infringement 2 claims regarding all patents on those External link to document
2018-06-05 30 Redacted Document xiii. U.S. Patent No. 7,449,184 (“the ’184 patent”); xiv. U.S. Patent No. 7,485,704…what purports to be a copy of U.S. Patent No. 7,449,184 (“’184 Patent”) is attached to the Complaint as… INFRINGEMENT OF U.S. PATENT NO. 7,449,184 Defendants repeat and incorporate… Upon information and belief, U.S. Patent No. 7,449,184, titled “Fixed Dosing of HER Antibodies…Declaratory Judgment of Non-Infringement of U.S. Patent No. 7,449,184 Counterclaim-Plaintiffs External link to document
2018-07-10 38 Redacted Document xiii. U.S. Patent No. 7,449,184 (“the ’184 patent”); xiv. U.S. Patent No. 7,485,704…what purports to be a copy of U.S. Patent No. 7,449,184 (“’184 Patent”) is attached to the Complaint as… INFRINGEMENT OF U.S. PATENT NO. 7,449,184 Defendants repeat and incorporate… Upon information and belief, U.S. Patent No. 7,449,184, titled “Fixed Dosing of HER Antibodies…Declaratory Judgment of Non-Infringement of U.S. Patent No. 7,449,184 Counterclaim-Plaintiffs External link to document
2018-07-24 44 Redacted Document 660 patent”); (xiii) U.S. Patent No. 7,449,184 (“the ’184 patent”); (xiv) U.S. Patent No. 7,485,704…(“the ’660 patent”); xiii. U.S. Patent No. 7,449,184 (“the ’184 patent”); …xiii. U.S. Patent No. 7,449,184 (“the ’184 patent”); xiv. U.S. Patent No. 7,485,704…Declaratory Judgment of Non-Infringement of U.S. Patent No. 7,449,184 199. 233. PlaintiffsCounterclaim-Plaintiffs…Declaratory Judgment of Invalidity of U.S. Patent No. 7,449,184 205. 239. PlaintiffsCounterclaim-Plaintiffs External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.